Luc Manlay

Effectiveness of Switching From Intravenous to Subcutaneous Infliximab in Patients With Inflammatory Bowel Diseases: the REMSWITCH Study

Anthony Buisson, Maria Nachury, Maud Reymond et al. · Clinical Gastroenterology and Hepatology · 2022 · 88 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +13

Ustekinumab is more effective than azathioprine to prevent endoscopic postoperative recurrence in Crohn's disease

Anthony Buisson, Stéphane Nancey, Luc Manlay et al. · United European Gastroenterology Journal · 2021 · 50 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +16

Comparison of short‐ and long‐term effectiveness between ustekinumab and vedolizumab in patients with Crohn's disease refractory to anti‐tumour necrosis factor therapy

Luc Manlay, Gilles Boschetti, Bernard Flourié et al. · Alimentary Pharmacology & Therapeutics · 2021 · 50 citations

Pharmacy, Clinical Sciences, Pharmacotherapy +15

Top-down Versus Step-up Strategies to Prevent Postoperative Recurrence in Crohn’s Disease

Anthony Buisson, Lysa Blanco, Luc Manlay et al. · Inflammatory Bowel Diseases · 2022 · 15 citations · Full text

Medicine, Clinical Sciences, Surgery +13